Monograph Details
|
|
Nutrition
> Obesity
|
|
IONAMIN |
| Manufacturer |
|
UCB Inc. |
| Legal Classification |
|
CIV |
| Pharmacological Class |
|
Sympathomimetic. |
| Generic Name |
|
Phentermine (as resin) 15mg, 30mg; caps. |
| Indications |
|
Short-term adjunct in management of exogenous obesity. |
| Children |
|
Not recommended. |
| Adults |
|
Swallow whole. 15–30mg before breakfast or 10–14 hrs before bedtime. |
| Contraindications |
|
During or within 14 days of MAOIs. Arteriosclerosis. Cardiovascular disease. Hypertension. Hyperthyroidism. Glaucoma. Agitation. Drug or alcohol abuse. |
| Precautions |
|
Discontinue if tolerance to anorectic effect occurs. Diabetes. Avoid hazardous activities. Prescribe limited supply to avoid overdose. Pregnancy. |
| Interactions |
|
Hypertensive crisis with MAOIs. Decreases hypotensive effect of adrenergic blockers. Avoid alcohol. Possible risk of valvular heart disease with fenfluramine. |
| Adverse Reactions |
|
Abuse potential, hypertension, arrhythmias, CNS overstimulation and other effects, dry mouth, GI disturbances, psychosis, urticaria, impotence. |
| How Supplied |
|
Caps—100, 400 |
|
|
|
|
